X-linked complex spastic paraplegia

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:98888
Who is this for?
Show terms as
8Treatment centers1Financial resources

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Also known as:

Orphanet ↗NORD ↗

FDA & Trial Timeline

10 events
Mar 2026

CABERGOLINE: New indication approved

FDAcompleted
Mar 2026IOPIDINE 1%: New indication approved
FDAcompleted
Mar 2026

OXALIPLATIN: New indication approved

FDAcompleted
Mar 2026TOBRADEX ST: New indication approved
FDAcompleted
Feb 2026REBLOZYL: New indication approved
FDAcompleted
Jan 2026ALVAIZ: New indication approved
FDAcompleted
Feb 2022

OXALIPLATIN: New indication approved

FDAcompleted
Dec 2019

CABERGOLINE: New indication approved

FDAcompleted
Mar 2017

OXALIPLATIN: FDA approved

FDAcompleted
Oct 2011

CABERGOLINE: New indication approved

FDAcompleted

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for X-linked complex spastic paraplegia.

View clinical trials →

No actively recruiting trials found for X-linked complex spastic paraplegia at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the X-linked complex spastic paraplegia community →

No specialists are currently listed for X-linked complex spastic paraplegia.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Financial Resources

1 resources

MIPLYFFA

Acer Therapeutics Inc.

Unverified — confirm before calling
copay card
copay assistancePatient Assistance
Accepting applications

Travel Grants

No travel grants are currently matched to X-linked complex spastic paraplegia.

Search all travel grants →NORD Financial Assistance ↗

Community

Open X-linked complex spastic paraplegiaForum →

No community posts yet. Be the first to share your experience with X-linked complex spastic paraplegia.

Start the conversation →

Latest news about X-linked complex spastic paraplegia

3 articles
NewsFDA
FDA Approves CABERGOLINE
CABERGOLINE (CABERGOLINE) received FDA approval.
NewsFDA
FDA Approves OXALIPLATIN
OXALIPLATIN (OXALIPLATIN) received FDA approval.
NewsFDA
FDA Approves TOBRADEX ST
TOBRADEX ST (DEXAMETHASONE) received FDA approval.
See all news about X-linked complex spastic paraplegia

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about X-linked complex spastic paraplegia

What treatment and support options exist for X-linked complex spastic paraplegia?

1 patient support program are currently tracked on UniteRare for X-linked complex spastic paraplegia. See the treatments and support programs sections for copay assistance, eligibility, and contact details.